Preclinical and mechanistic studies have shown promise
It does not cause dependence, does not interact with GLP-1 receptor agonists, and works through an osmotic mechanism rather than stimulating the colon directly
[7] [8] The concept of GLP-1 balance has gained clinical relevance with the development of GLP-1 receptor agonists (such as semaglutide and liraglutide) for glycemic control and, at specific FDA-approved doses, chronic weight management
Patients should also understand realistic expectations for these medications
Treat the countdown as a marketing device rather than a confirmed, one-time deadline, and don't let it pressure a purchase decision you wouldn't otherwise make
They specialize in weight management and hormone therapy, offering a range of GLP-1 medications to help individuals achieve their health goals